Literature DB >> 26953237

Properties of Ultraviolet Exposed Camptothecin Studied by Using Optical Spectroscopy Methods.

Blanka Ziomkowska1, Tomasz Wybranowski, Michal Cyrankiewicz, Stefan Kruszewski.   

Abstract

Camptothecin (CPT) and its analogs as inhibitors of topoisomerase I are anticancer compounds. Their antitumor potency is seriously limited due to hydrolysis of lactone form of camptothecins in solutions at pH>5.5, which leads to the formation of inactive carboxylate form with open lactone ring. Furthermore, the clinical application of CPT is also restricted by strong affinity of its carboxylate form to human serum albumin which destabilizes the active lactone form. By UV irradiation of the CPT carboxylate authors of this paper received camptothecin compound which has biophysical properties similar to the lactone form. The specific objective of the project is to determine the properties using the methods of absorption and steady-state fluorescence spectra analysis, fluorescence lifetime measurements as well as steady-state fluorescence anisotropy. The results suggest that the UV exposed camptothecin carboxylate changes the chemical structure. The high-throughput assays based on the steady state fluorescence anisotropy measurements proved that the form obtained as a result of UV irradiation of CPT carboxylate exhibits weaker affinity to albumin than CPT carboxylate however stronger than CPT lactone. This property is very desirable from the point of view of clinical applications.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26953237     DOI: 10.2174/1386207319666160308130643

Source DB:  PubMed          Journal:  Comb Chem High Throughput Screen        ISSN: 1386-2073            Impact factor:   1.339


  1 in total

1.  Understanding the driving forces of camptothecin interactions on the surface of nanocomposites based on graphene oxide decorated with silica nanoparticles.

Authors:  Leandro C Fonseca; Marcelo de Sousa; Djalma L S Maia; Luis Visani de Luna; Oswaldo L Alves
Journal:  Nanoscale Adv       Date:  2020-02-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.